[Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
D000631:Aminopyridines / Q000627:therapeutic use; D000676:Amrinone; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007288:Inosine / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000631:Aminopyridines; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D011799:Quinazolines; D013566:Sympathomimetics; D007288:Inosine; D006632:Histamine; D005934:Glucagon; C040850:quazinone; C029758:sulmazole; D000676:Amrinone
La terapia inotropa positiva dello scompenso cardiaco: farmaci vecchi e nuovi, controversie e prove.